	Rewiring tumor cytokine networks to enhance immune checkpoint blockade: mechanisms, engineering, and clinical translation. J Exp Clin Cancer Res Wang X, Wang J, Wang Q, Ding G, Huang Y, Feng Y. PMID: 41654940 [PubMed - as supplied by publisher]
	Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India. J Ovarian Res Yeshala SK, Panda SS, Moharana L, Saju SV, Rathinam K, Raju SH, Sehrawat A, Sundriyal D, Phillip AO, Kinsely PA, Bhatia KP, Kayal S, Dubashi B, Cyriac SL, Natarajan S, Samantaray L, Mohanty SS, Sadangi S, Pradhan S, Rana A, Ganesan P. PMID: 41654913 [PubMed - as supplied by publisher]
	Circulating extrachromosomal circular DNA as a prognostic biomarker for colorectal cancer. Cell Commun Signal Luo X, Cui J, Shi J, Sun G, Zhang L, Li Y, Guo Y, Kuai L, Sun T, Luo Q, Cai J, An Q, Zhang W, Xiao F, Zhao G. PMID: 41654905 [PubMed - as supplied by publisher]
	Potential correlation between high SNHG expression and poor pancreatic cancer prognosis: evidence from systematic reviews and meta-analyses. Cancer Cell Int Du SQ, Liu YT, Yang F, Zhang J. PMID: 41654901 [PubMed - as supplied by publisher]
	Advances in green-synthesized magnetic nanoparticles for targeted cancer therapy: mechanisms, applications, and future perspectives. Eur J Med Res El-Khawaga AM, Youssef OI, El-Dydamoni OA, Ragab WM, Mohammed RAE. PMID: 41654877 [PubMed - as supplied by publisher]
	Ubiquitin-centered post-translational modification crosstalk orchestrates tumor immunity and immunotherapy response. Exp Hematol Oncol Qiao K, Wu L, Yang L, Liu M, Jiang C, Chen Y, Zhang Z, Yu J, Wei D, Xu Y. PMID: 41654863 [PubMed - as supplied by publisher]
	Comparison of timing for early postoperative intake in patients with upper gastrointestinal cancer: a network meta-analysis. BMC Surg Yang Z, Fan Y, Wei J, Nan L, Li Q. PMID: 41654844 [PubMed - as supplied by publisher]
	Neutrophils in nasopharyngeal carcinoma: from mechanisms to therapeutics. J Transl Med Liu W, You B, Miao Z, Yu J, Ding X, Zhou C. PMID: 41654839 [PubMed - as supplied by publisher]
	Next-generation dynamic and combinatorial nanotherapies for liver cancer: mechanisms, current advances and future perspectives. J Nanobiotechnology Zhang B, Iqbal MS, Yan Y, Wang H, Wang X, Zhang Y, Guo B. PMID: 41654811 [PubMed - as supplied by publisher]
	Efficacy and safety of treatments in HR+/HER2- advanced breast cancer after CDK4/6 inhibitor progression: a network meta-analysis and scoping review. BMC Cancer Zhang L, Sun F, Wang X, Zhao W, Jia Y, Wang H, Han Y, Tong Z. PMID: 41654790 [PubMed - as supplied by publisher]
	Cardioprotective effects of dapagliflozin against doxorubicin-induced cardiotoxicity in breast cancer patients with type 2 diabetes: a prospective study. BMC Cancer Ozturk HA, Koc M, Okyay RA, Ozturk DD, Gulumsek E, Buyuksimsek M, Turker M, Cetin AE, Arici FN, Sumbul HE. PMID: 41654775 [PubMed - as supplied by publisher]
	Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma. Sci Rep Li S, Qin J, Sun Q, Zhao H, Xiong Y, Wang Y, Han Y, Zhang J, Zhang W, Shen M, Yang F, Ren B, Zhou L, Li R, Hui Z, Tian X, Cao S, Du W, Yu W, Liu L, Zhang X, Ren X. PMID: 41654611 [PubMed - as supplied by publisher]
	Pathways to lung cancer diagnosis and treatment among patients in Ethiopia: A qualitative study. Sci Rep Estifanos N, Egata G, Addissie A, Kaba M, Kebede RA, Worku A, Bitew A, Assefa M, Habtamu B, Tesfaye S, Deyessa N. PMID: 41654605 [PubMed - as supplied by publisher]
	Hybrid vision transformer and graph neural network model with region-adaptive attention for enhanced skin cancer prediction. Sci Rep Dogga A, R S, S S. PMID: 41654513 [PubMed - as supplied by publisher]
	Statin use and outcomes in advanced prostate cancer:Secondary analysis of the SPARTAN trial. Urol Oncol Mousa A, Chavarriaga J, Lajkosz K, Penn LZ, Khurram N, Hamilton RJ. PMID: 41654482 [PubMed - as supplied by publisher]
	Predicting Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Model Development and Evaluation in an International Cohort Study. Clin Genitourin Cancer Weiner AB, Martin SC, Wilhalme H, Bailey AV, Kwan L, Awamlh BAHA, Zhao Z, Verze P, Ippolito J, La Rocca R, Sibert NT, Barocas DA, Belin TR, Elashoff D, Kowalski C, Foster C, Moore C, Litwin MS, True North Global Registry. PMID: 41654456 [PubMed - as supplied by publisher]
	Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol Contieri R, Paciotti M, Uleri A, Saita A, Taverna G, Sedigh O, Barra S, Colombo P, Porreca A, Beatrici E, Fasulo V, Avolio PP, Frego N, Finocchiaro A, Cella L, Collura D, Cieri M, Guazzoni G, Buffi NM, Lughezzani G, Casale P, Lazzeri M, Hurle R. PMID: 41654427 [PubMed - as supplied by publisher]
	ANCA positive pauci-immune glomerulonephritis as presenting feature of mantle cell lymphoma: A case report and review of literature. Nefrologia (Engl Ed) Kumru G, Yüksel M, Geri, Y, Kiremitci S, Kuzu I, Arslan Ö. PMID: 41654351 [PubMed - indexed for MEDLINE]
	Prognostic significance of hypermetabolic contralateral cervical lymph node in patients with oral and oropharyngeal squamous cell carcinoma. J Stomatol Oral Maxillofac Surg Hennocq Q, Truchard E, Chargari C, Maisonobe JA, Maingon P, Kas A, Bouaoud J, Bertolus C, Foy JP. PMID: 41654300 [PubMed - as supplied by publisher]
	Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma. J Hepatol Nault JC, Campani C, Hirsch TZ, Neumann E, Arif W, Imbeaud S, Baretti M, Ziol M, Sidali S, Roger P, Allaire M, Bouattour M, Marra F, Fresneau B, Llarch N, Peron JM, Gerolami R, Khac EN, Nahon P, Ganne-Carrié N, Caldéraro J, Beaufrère A, Paradis V, Guettier C, CAPRIH FFCD cohort, Sutton A, Yarchoan M, Zucman-Rossi J. PMID: 41654224 [PubMed - as supplied by publisher]

Articles 1 - 20 / 1907812

Page 1 of 95391



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy